Login
← Go Back
Piramal Pharma
PPLPHARMA · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 19, 2022
Stock Price vs Company Growth
1d
2.6%
1w
1.2%
1m
3.2%
3m
7.4%
6m
7.0%
1y
14.3%
all
1.9%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 174 2.6%
132
196
Company Overview
Sales
8,869 Cr
Growth: 0.2%
Profit after Tax
-347 Cr
Growth: 88.0%
Mid Cap
23,156 Cr
P/S: 2.6x
Industry P/S: 2.5x
Fundamentals
Sales (Cr) ₹ 8,869
Growth 0.2%
EBITDA 10.4%
P/S 2.6x
Dividend 0.1%
P/E -70.5x
Book Value ₹ 61.4
PEG Ratio -455.3x
ROE -4.3%
P/B 2.8x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is one of the India’s largest Pharmaceutical Company. PPL offers a portfolio of differentiated products and services through its global development and manufacturing facilities and a global distribution network in various countries.
Belongs to (31 Indices) view more
Investors (6)
vskr63
chethan3
ravi_kum...
Followers (2)
saurabh8...
varsha96